Prevalence of Pancreatic Steatosis in Pancreatic Cystic Neoplasms and Pancreatic Adenocarcinoma
Recruiting now
Conditions studied: Pancreatic Steatosis, Pancreatic Cyst, Pancreatic Adenocarcinoma
In brief
Several pancreatic neoplastic cystic lesions, such as IPMN (intrapapilary mucinous neoplasia), cystic neuroendocrine tumors (NET) and mucinous neoplasms, present a carcinogenetic risk, though it is yet unknown if this risk is increased in patients with pancreatic steatosis (PS). The primary objective of the study is to determine de prevalence of pancreatic steatosis in pancreatic neoplastic cysts and if pancreatic steatosis is increased in those lesions that pose a carcinogenetic risk. The secondary objective is to evaluate the prevalence of pancreatic steatosis in pancreatic adenocarcinoma.
Key facts
- Study ID
- NCT06867172
- Run by
- Carol Davila University of Medicine and Pharmacy
- People needed
- 66
- Starts
- 2019-01-01
- Expected to finish
- 2025-06-30
- Last updated by the study team
- 2025-03-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Age 18 or older
- Patients with at least 1 pancreatic cystic lesion based on CT and EUS features, with a cyst size ≥ 5mm; or healthy subjects or PDAC (confirmed by histopathological exam).
You may not qualify if…
- No evidence of written informed consent
- Patients with contraindications for endoscopy due to comorbidities
- Metal stent in hepato-bilio-pancreatic region at time of baseline CT-imaging (vascular, luminal and biliary)
- Acute pancreatitis at baseline imaging
- Pancreatic surgery at baseline imaging in our department
- Splenectomy
- Patients with significant alcohol consumption, defined as alcohol intake of over 20 g daily (140 g weekly) for men and 10 g daily (70 g weekly) for women
Where it is running
- Prof Dr Agrippa Ionescu; Clinical Emergency Hospital — Bucharest, Sector 1, Romania (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.